The Associated Press reports that Astra Zeneca has agreed to pay a $520 million settlement to the Federal government to resolve allegations of illegally marketing its anti-psychotic drug, Seroquel.
The company was alleged to have “marketed Seroquel for off-label uses — those not approved by federal drug regulators — including insomnia and psychiatric conditions other than schizophrenia and bipolar disorder.”